Inducible expression of p21(WAF-1/CIP-1/SDI-1) from a promoter conversion retroviral vector

被引:17
作者
Mrochen, S
Klein, D
Nikol, S
Smith, JR
Salmons, B
Gunzburg, WH
机构
[1] UNIV VET SCI,INST VIROL,A-1210 VIENNA,AUSTRIA
[2] GSF,NAT RES CTR ENVIRONM & HLTH,INST MOL VIROL,OBERSCHLEISSHEIM,GERMANY
[3] UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN 1,D-8000 MUNICH,GERMANY
[4] BAVARIAN NORD RES INST,MUNICH,GERMANY
[5] BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030
[6] BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030
[7] BAYLOR COLL MED,DIV MOL VIROL,HUFFINGTON CTR AGING,HOUSTON,TX
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1997年 / 75卷 / 11-12期
关键词
retroviral vector; conditional expression; cell cycle control; mouse mammary tumor virus long terminal repeat; WAF-1/CIP-1/SDI-1;
D O I
10.1007/s001090050171
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Constitutive, high-level expression of the potentially therapeutic WAF-1/CIP-1/SDI-1 gene is incompatible with cell growth. A promoter conversion retroviral vector carrying the WAF-1/CIP-1/SDI-1 gene under the transcriptional control of the glucocorticoid inducible promoter of mouse mammary tumor virus was used to infect human bladder carcinoma or feline kidney cells. Reduced cell growth due to a greater proportion of cells being in the G(0)/G(1) phase of the cell cycle was observed when WAF-1/CIP-1/SDI-1 expression was activated by addition of glucocorticoid hormone. This system demonstrates the potential long-term therapeutic use of WAF-1/CIP-1/SDI-1 delivered by retroviral vectors for inhibiting the growth of rapidly proliferating cells, Moreover. the conditional expression of genes such as WAF-1/CIP-1/SDI-1 from such retroviral vectors may facilitate analysis of their function.
引用
收藏
页码:820 / 828
页数:9
相关论文
共 24 条
[1]   VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS [J].
BURNS, JC ;
FRIEDMANN, T ;
DRIEVER, W ;
BURRASCANO, M ;
YEE, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8033-8037
[2]  
CRANDELL RA, 1973, IN VITRO CELL DEV B, V9, P176, DOI 10.1007/BF02618435
[3]  
ELDIERY WS, 1993, CELL, V75, P817
[4]   MOUSE MAMMARY-TUMOR VIRUS MEDIATED TRANSFER AND EXPRESSION OF NEOMYCIN RESISTANCE TO INFECTED CULTURED-CELLS [J].
GUNZBURG, WH ;
SALMONS, B .
VIROLOGY, 1986, 155 (01) :236-248
[5]   VIRUS VECTOR DESIGN IN GENE-THERAPY [J].
GUNZBURG, WH ;
SALMONS, B .
MOLECULAR MEDICINE TODAY, 1995, 1 (09) :410-417
[6]  
GUNZBURG WH, 1992, BIOCHEM J, V283, P625
[7]  
GUNZBURG WH, 1996, MOL MED TODAY, V74, P171
[8]  
HARPER JW, 1993, CELL, V75, P805
[9]   THE V-MOS AND H-RAS ONCOGENE EXPRESSION REPRESSES GLUCOCORTICOID HORMONE-DEPENDENT TRANSCRIPTION FROM THE MOUSE MAMMARY-TUMOR VIRUS LTR [J].
JAGGI, R ;
SALMONS, B ;
MUELLENER, D ;
GRONER, B .
EMBO JOURNAL, 1986, 5 (10) :2609-2616
[10]  
JIANG HP, 1994, ONCOGENE, V9, P3397